Target Site Pharmacokinetics of Doripenem at Steady State in Intubated Intensive Care Patients

A Clinical Study to Measure the Effect of OP-101 After Being Administered Subcutaneous in Healthy Volunteers

NCT04321980 ·Status: COMPLETED ·Phase: PHASE1

A Study Evaluating the Pharmacokinetics of Doravirine (MK-1439) in Participants With Severe Renal Impairment (MK-1439-051)

NCT02641067 ·Status: COMPLETED ·Phase: PHASE1

Prospective, Open-label Study of Pharmacokinetics of Ertapenem in the Muscle Using Microdialysis in Mechanically Ventilated Intensive Care Unit Patients, Treated or Not by Norepinephrine

NCT00489138 ·Status: TERMINATED ·Phase: PHASE4

Pharmacokinetics of Gepotidacin Tablets in Adults and Adolescents Subjects

NCT04079790 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Effect of Mild, Moderate, and Severe Hepatic Impairment on Pharmacokinetics of Sitravatinib

NCT04772612 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Study of Daptomycin in Healthy Chinese Subjects Living in China

NCT00858325 ·Status: COMPLETED ·Phase: PHASE1

A Study to Investigate the Pharmacokinetics of ACT-1014-6470 in Subjects With Severe Renal Impairment Compared to Control Subjects

NCT04899219 ·Status: COMPLETED ·Phase: PHASE1

Clinical Study to Assess the Pharmacokinetics, Safety, and Tolerability of ACT-129968 in Healthy Subjects

NCT01877629 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetic Study of Stiripentol and Its Metabolites After Multiple Dose Oral Administration in Healthy Male Volunteers

NCT03866928 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics of Two Different High-dose Regimens of Intravenous Vitamin C in Critically Ill Patients

NCT02455180 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetics of Benapenem in Subjects With Renal Impairment

NCT04476407 ·Status: COMPLETED ·Phase: PHASE1

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of PUR3100 in Health Adults

NCT05351086 ·Status: COMPLETED ·Phase: PHASE1

A Biopharmaceutics Study to Assess the Pharmacokinetics of Single Oral and IV Doses of Olorofim

NCT04207957 ·Status: COMPLETED ·Phase: PHASE1

Pharmacokinetics (PK) of Ertapenem Intravenous (IV) Bolus Versus Standard Infusion

NCT01148771 ·Status: COMPLETED ·Phase: PHASE4

Pharmacokinetic Study of Aztreonam-Avibactam in Severe Renal Impairment

NCT04486625 ·Status: COMPLETED ·Phase: PHASE1

A Study to Compare the Safety, Tolerability, and Pharmacokinetics of CTP-692 Versus D-serine in Healthy Volunteers

NCT03778320 ·Status: COMPLETED ·Phase: PHASE1

A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers

NCT00619931 ·Status: COMPLETED ·Phase: PHASE1

Lipid and Adipokine Profiles Following Subcutaneous Injection of ATX-101 Into Abdominal Fat Tissue

NCT01319916 ·Status: COMPLETED ·Phase: PHASE1

Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of ACT-389949

NCT02099071 ·Status: COMPLETED ·Phase: PHASE1

A Two-part Pharmacokinetic Study of PXS-5382A in Healthy Adult Males

NCT04183517 ·Status: COMPLETED ·Phase: PHASE1

A Study To Investigate The Pharmacokinetics, Safety And Tolerability Of An Intravenous And Oral Form Of A Compound In Subjects With Varying Degrees Of Renal Impairment And Normal Renal Function

NCT00759564 ·Status: COMPLETED ·Phase: PHASE1

Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD0780

NCT06576765 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate Pharmacokinetics, Safety and Efficacy of CM310

NCT05702450 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating the Pharmacokinetics of CM310 in Healthy Subjects

NCT06171048 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1

A Pharmacokinetic Study of MABp1 in Healthy Volunteers

NCT03047317 ·Status: COMPLETED ·Phase: PHASE1